🇩🇰 Denmark Country × Condition
acute myeloid leukemia Clinical Trials in Denmark
Active clinical trials for acute myeloid leukemia with research sites in Denmark. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 3, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇩🇰 Denmark
Active Trials in Denmark (3)
NCT07075016 Phase 3
Recruiting
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
Enrollment
227 pts
Country
🇩🇰 Denmark
Stichting Hemato-Oncologie voor Vol...
View Trial → NCT05431257 Phase 2
Recruiting
Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling
Enrollment
117 pts
Country
🇩🇰 Denmark
Rigshospitalet, Denmark
View Trial → NCT03999723 Phase 2
Recruiting
Combining Active and Passive DNA Hypomethylation
Enrollment
196 pts
Country
🇩🇰 Denmark
Kirsten Grønbæk
View Trial → Frequently Asked Questions
How many acute myeloid leukemia clinical trials are active in Denmark?
There are currently 3 active clinical trials for acute myeloid leukemia with sites in Denmark, of which 3 are actively recruiting patients.
How can I join a acute myeloid leukemia clinical trial in Denmark?
To join a acute myeloid leukemia clinical trial in Denmark, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Denmark directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are acute myeloid leukemia trials in Denmark?
Active acute myeloid leukemia trials in Denmark span Phase 3, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology